Joseph Romanelli's most recent trade in Merck & Co Inc was a trade of 2,262 Common Stock done at an average price of $83.3 . Disclosure was reported to the exchange on April 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.26 per share. | 30 Apr 2025 | 2,262 | 24,060 (0%) | 0% | 83.3 | 188,334 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 2,262 | 2,262 | - | - | Restricted Stock Unit | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.71 per share. | 30 Apr 2025 | 2,063 | 22,815 (0%) | 0% | 84.7 | 174,757 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 2,063 | 4,128 | - | - | Restricted Stock Unit | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.26 per share. | 30 Apr 2025 | 1,115 | 22,945 (0%) | 0% | 83.3 | 92,835 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.71 per share. | 30 Apr 2025 | 1,017 | 21,798 (0%) | 0% | 84.7 | 86,150 | Common Stock |
| Kimberly-Clark | Joseph Romanelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,493 | 1,726 | - | - | Restricted Share Units | |
| Kimberly-Clark | Joseph Romanelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 233 | 233 | - | - | Restricted Share Units | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 23,438 | 23,438 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 6,191 | 6,191 | - | - | Restricted Stock Unit | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.80 per share. | 30 Apr 2024 | 2,262 | 21,831 (0%) | 0% | 128.8 | 291,346 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 2,262 | 4,524 | - | - | Restricted Stock Unit | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.80 per share. | 30 Apr 2024 | 1,115 | 20,716 (0%) | 0% | 128.8 | 143,612 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 124.89 per share. | 13 Feb 2024 | 1,000 | 19,569 (0%) | 0% | 124.9 | 124,888 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 107.37 per share. | 02 Aug 2023 | 59 | 0 (0%) | 0% | 107.4 | 6,335 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 107.37 per share. | 02 Aug 2023 | 30 | 20,569 (0%) | 0% | 107.4 | 3,221 | Common Stock |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 23,513 | 23,513 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 6,786 | 6,786 | - | - | Restricted Stock Unit | |
| Merck & Company | Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 108.22 per share. | 15 Feb 2023 | 5,000 | 20,284 (0%) | 0% | 108.2 | 541,101 | Common Stock |